药品名称GLUCAGON
申请号012122产品号002
活性成分GLUCAGON HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格EQ 10MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ELI LILLY AND CO
化学类型New molecular entity (NME)审评分类Priority review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
012122043AP1998/06/26Control Supplement
012122042AP1997/09/23Manufacturing Change or Addition
012122041AP1998/01/08Control Supplement
012122040AP1997/04/18Labeling Revision
012122039AP1997/05/12Labeling Revision
012122038AP1996/11/07Control Supplement
012122037AP1996/12/13Control Supplement
012122036AP1995/12/15Labeling Revision
012122035AP1996/04/19Manufacturing Change or Addition
012122034AP1993/04/28Labeling Revision
012122033AP1991/11/19Control Supplement
012122032AP1990/10/01Labeling Revision
012122031AP1990/10/11Labeling Revision
012122030AP1990/10/04Labeling Revision
012122029AP1988/12/02Labeling Revision
012122028AP1988/09/30Package Change
012122027AP1988/01/05Labeling Revision
012122026AP1991/04/03Manufacturing Change or Addition
012122025AP1986/09/30Labeling Revision
012122022AP1985/10/17Control Supplement
012122022AP1985/10/17Labeling Revision
012122019AP1984/12/13Labeling Revision
012122018AP1984/08/09Labeling Revision
012122017AP1984/08/02Control Supplement
012122016AP1983/07/21Labeling Revision
012122015AP1981/10/09Manufacturing Change or Addition
012122014AP1981/06/15General Efficacy (MarkIV)
012122013AP1980/02/21General Efficacy (MarkIV)
012122012AP1979/11/27General Efficacy (MarkIV)
012122010AP1975/12/31Control Supplement
012122009AP1975/01/27Control Supplement
012122008AP1975/05/20Control Supplement
012122000AP1960/11/14Approval